

Members of the tumor necrosis
factor receptor (TNFR) superfamily are potent regulators of apoptosis, a
process that is important for the maintenance of immune homeostasis. Recent
evidence suggests that TNFR-1, Fas and TRAIL receptors can also trigger an
alternative form of cell death that is morphologically distinct from apoptosis.
Because distinct molecular components including the protein serine/threonine
kinase RIP are required, we have referred to this alternative form of cell
death as programmed necrosis. We showed that TNFR-2 signaling could potentiate
programmed necrosis via TNFR-1. When cells were pre-stimulated through TNFR-2
prior to subsequent activation of TNFR-1, enhanced cell death and recruitment
of RIP to the TNFR-1 complex was observed. However, TNF-induced programmed
necrosis was normally inhibited by caspase-8 cleavage of RIP. To ascertain the
physiological significance of RIP and programmed necrosis, we infected Jurkat
cells with vaccinia virus (VV) and found that VV-infected cells underwent
programmed necrosis in response to TNF, but deficiency of RIP rescued the
infected cells from TNF-induced cytotoxicity. Moreover, TNFR-2-/- mice
exhibited reduced inflammation in the liver and defective viral clearance
during VV infection. Interestingly, death effector domain (DED) containing
proteins such as MC159, E8, K13 and cFLIP, but not the apoptosis inhibitors
Bcl-XL, p35 or XIAP, potently suppressed programmed necrosis. Thus, TNF-induced
programmed necrosis is facilitated by TNFR-2 signaling and caspase inhibition
and may play a role in controlling virus infection.